HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment-Reference-Cited by-同舟云学术

HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment

Published:2017-05-31 Issue:8 Volume:264 Page:1715-1727
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Eggers Christian^ORCID, ,Arendt Gabriele,Hahn Katrin,Husstedt Ingo W.,Maschke Matthias,Neuen-Jacob Eva,Obermann Mark,Rosenkranz Thorsten,Schielke Eva,Straube Elmar

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/article/10.1007/s00415-017-8503-2/fulltext.html

Reference132 articles.

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799

2. Arendt G, Hefter H, Elsing C, Strohmeyer G, Freund HJ (1990) Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit. J Neurol 237:362–368

3. Arendt G, Hefter H, Hilperath F, von Giesen HJ, Strohmeyer G, Freund HJ (1994) Motor analysis predicts progression in HIV-associated brain disease. J Neurol Sci 123:180–185

4. Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C, Phillips A, Porter K (2008) Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 63:213–221

5. Brew B (2004) Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18(Suppl 1):S75–S78

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Infection and AIDS;Massachusetts General Hospital Comprehensive Clinical Psychiatry;2025

2. HIV-TAT dysregulates microglial lipid metabolism through SREBP2/miR-124 axis: Implication of lipid droplet accumulation microglia in NeuroHIV;Brain, Behavior, and Immunity;2025-01

3. Antiretroviral efficacy versus neurotoxicity;The Lancet HIV;2024-09

4. Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants;Journal of NeuroVirology;2024-08-12

5. HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis;Frontiers in Microbiology;2024-08-02